Is interleukin‐27 a real candidate for immunotherapies of multiple sclerosis?
Clinical and Experimental Neuroimmunology · 2013
DOI: 10.1111/cen3.12014 ↗Abstract
Abstract As interleukin ( IL )‐27 has immunosuppressive effects and blocks T h17 differentiation, some researchers have investigated the possibility of the use of IL ‐27 for treatment of autoimmune diseases including multiple sclerosis. However, it has now been shown that the functions of IL ‐27 are more pleomorphic than expected. Therefore, more detailed analysis is necessary before entering this phase.
EUVIMED